Chiriac Anca, Giardi Davide, Cheema Kamal P, Espinosa Samantha, Umadat Goyal, Hodge David O, Madhavan Malini, Asirvatham Samuel, Phillips Sabrina D, McLeod Christopher J
Department of Cardiovascular Diseases, Mayo Clinic, Jacksonville, FL, USA.
Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
Int J Cardiol Congenit Heart Dis. 2024 Jan 2;15:100491. doi: 10.1016/j.ijcchd.2023.100491. eCollection 2024 Mar.
Patients with D-transposition of the great arteries (D-TGA) and atrial switch experience late morbidity and mortality related to atrial arrhythmias and systemic right ventricular (SRV) failure. We sought to analyze the influence of atrial arrhythmias on long-term outcomes in this group.
A retrospective review of all patients with D-TGA and atrial switch followed at a tertiary care center was performed.
148 patients (63.5 % male; age 30.4 ± 10.6 years) were followed for 12 ± 9.8 years. Death or cardiac transplantation occurred in 22(15 %) patients and heart failure hospitalization occurred in 30(20 %) patients.Atrial arrhythmias were documented in 82(55.4 %) patients. Atrial fibrillation at the first visit (Kaplan-Meier estimate, p = 0.003) and atrial fibrillation as a time-dependent variable (HR 3.50, p = 0.006) predicted increased risk of death or cardiac transplantation. A triad of atrial fibrillation, prolonged QRS duration/RBBB, and severe SRV dysfunction (SRV EF < 35 %) emerged as a unique signature of a higher-risk population.Atrial tachycardia and flutter, while not associated with mortality, increased the risk of heart failure hospitalization (HR 3.5, p = 0.001). Moreover, 2/6 cases of resuscitated sudden cardiac arrest were caused by atrial flutter, and more patients received inappropriate shocks for atrial arrhythmias(16 %) than appropriate shocks(2.3 %).
In D-TGA patients with atrial switch, there is a complex interplay between atrial arrhythmias and the SRV. Key ECG parameters, arrhythmia events and sequelae create a unique patient-specific fingerprint strongly associated with future events and mortality. This higher-risk cohort will need further characterization to delineate who may benefit from preemptive arrhythmia intervention.
大动脉转位(D-TGA)且接受心房调转术的患者会经历与房性心律失常和系统性右心室(SRV)衰竭相关的晚期发病率和死亡率。我们试图分析房性心律失常对该组患者长期预后的影响。
对在一家三级医疗中心随访的所有D-TGA且接受心房调转术的患者进行回顾性研究。
148例患者(63.5%为男性;年龄30.4±10.6岁)接受了12±9.8年的随访。22例(15%)患者发生死亡或心脏移植,30例(20%)患者因心力衰竭住院。82例(55.4%)患者记录到房性心律失常。首次就诊时的心房颤动(Kaplan-Meier估计值,p = 0.003)以及作为时间依赖性变量的心房颤动(HR 3.50,p = 0.006)预示着死亡或心脏移植风险增加。心房颤动、QRS时限延长/右束支传导阻滞以及严重的SRV功能障碍(SRV射血分数<35%)这三者构成了高风险人群的独特特征。房性心动过速和心房扑动虽与死亡率无关,但增加了心力衰竭住院风险(HR 3.5,p = 0.001)。此外,6例复苏成功的心脏骤停中有2例由心房扑动引起,因房性心律失常接受不适当电击的患者(16%)多于接受适当电击的患者(2.3%)。
在接受心房调转术的D-TGA患者中,房性心律失常与SRV之间存在复杂的相互作用。关键的心电图参数、心律失常事件及其后遗症构成了独特的患者特异性特征,与未来事件和死亡率密切相关。这一高风险队列需要进一步明确特征,以确定哪些患者可能从预防性心律失常干预中获益。